Publication | Closed Access

Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice

InflammationAcute Lung InjuryAnti-inflammatoryInflammatory Lung DiseaseLung InflammationMedicineImmunologyChronic InflammationLps-induced Pulmonary InflammationPulmonary PharmacologyPulmonary FibrosisNf-κb ActivationPharmacologyPulmonary Disease